Stock listing

NASDAQ:IMRX Immuneering Corporation Stock

Home listing (NASDAQ) of Immuneering Corporation

Follow Immuneering Corporation into a list and get an email when it puts out news.

Share price · NASDAQ:IMRX

$3.75 USD -0.27 (-6.8%)

Close on Oct 30, 2026

Past year -41.6% · daily closes, Oct 30, 2025 – Oct 30, 2026, adjusted for splits
Day range
$3.72 – $4.07 USDOct 30, 2026
Volume
1.14M sharesOct 30, 2026
Market cap
$242.3M USDAt the close on Oct 30, 2026 · price × 64.70M shares outstanding
52-week range
$3.38 – $8.48 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
Traded on an average day
$3.08M USDMedian day 610,950 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Immuneering Corporation logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:IMRX · Home$3.745 USD-0.275 (-6.8%)1,138,655$4.01$4.07$3.72$4.02Close on Oct 30, 2026

Daily closes

Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:IMRX · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$3.745-0.275-6.8%$4.01$4.07$3.721,138,655
$4.02+0.03+0.8%$3.99$4.10$3.875770,876
$3.99+0.16+4.2%$3.80$4.155$3.791,442,484
$3.83+0.12+3.2%$3.72$3.888$3.70699,488
$3.71-0.02-0.5%$3.73$3.775$3.66579,759
$3.73-0.08-2.1%$3.78$3.78$3.585726,538
$3.81+0.07+1.9%$3.72$3.835$3.70527,134
$3.74+0.01+0.3%$3.73$3.80$3.68481,881
$3.73+0.07+1.9%$3.70$3.841$3.67926,844
$3.66+0.07+1.9%$3.61$3.67$3.56427,112
$3.59-0.05-1.4%$3.65$3.68$3.575747,900
$3.64+0.22+6.4%$3.42$3.71$3.38934,300
$3.42-0.14-3.9%$3.51$3.598$3.41803,700
$3.56-0.30-7.8%$3.86$3.86$3.545734,400
$3.86-0.08-2.0%$3.94$3.945$3.814529,700
$3.94+0.20+5.3%$3.75$3.955$3.68709,700
$3.74-0.12-3.1%$3.83$3.83$3.601,922,000
$3.86+0.03+0.8%$3.78$3.915$3.74747,700
$3.83-0.21-5.2%$4.06$4.09$3.81898,400
$4.04-0.03-0.7%$4.07$4.12$4.02479,700
$4.07+0.04+1.0%$4.10$4.145$4.02588,800
$4.03-0.065-1.6%$4.10$4.17$4.01538,200
$4.095-0.035-0.8%$4.16$4.23$4.09596,800
$4.13-0.03-0.7%$4.16$4.16$4.065574,400
$4.16-0.11-2.6%$4.25$4.25$4.125597,900
$4.27-0.07-1.6%$4.36$4.40$4.255513,400
$4.34-0.04-0.9%$4.36$4.38$4.20589,600
$4.38-0.23-5.0%$4.62$4.65$4.355551,500
$4.61+0.17+3.8%$4.50$4.665$4.45590,400
$4.44-0.04-0.9%$4.55$4.57$4.38540,300
$4.48+0.02+0.4%$4.46$4.52$4.4151,077,900
$4.46+0.01+0.2%$4.55$4.55$4.405576,100
$4.45+0.01+0.2%$4.45$4.505$4.398899,800
$4.44+0.11+2.5%$4.33$4.475$4.24862,100
$4.33+0.06+1.4%$4.28$4.435$4.26493,800
$4.27-0.30-6.6%$4.63$4.65$4.24901,400
$4.57-0.04-0.9%$4.53$4.685$4.47624,000
$4.61-0.17-3.6%$4.74$4.81$4.541,165,700
$4.78-0.04-0.8%$4.82$4.885$4.6851,043,900
$4.82-0.22-4.4%$4.94$5.00$4.805999,900
$5.04+0.02+0.4%$5.085$5.105$4.93424,400
$5.02+0.17+3.5%$4.85$5.055$4.80678,600
$4.85-0.14-2.8%$4.90$4.985$4.84435,000
$4.990.000.0%$5.00$5.01$4.863587,400
$4.99-0.22-4.2%$5.21$5.214$4.935793,700
$5.21+0.06+1.2%$5.19$5.395$5.12787,700
$5.15-0.08-1.5%$5.23$5.23$5.109460,000
$5.23+0.05+1.0%$5.20$5.38$5.20364,300
$5.18-0.12-2.3%$5.31$5.35$5.125400,571
$5.30+0.05+1.0%$5.31$5.43$5.281443,600
$5.25-0.08-1.5%$5.25$5.37$5.20473,200
$5.33+0.30+6.0%$5.18$5.37$5.14751,100
$5.03-0.19-3.6%$5.14$5.20$4.96512,500
$5.22+0.16+3.2%$5.00$5.27$4.99486,500
$5.06-0.14-2.7%$5.18$5.18$4.93523,800
$5.20+0.13+2.6%$5.06$5.26$5.061,083,700
$5.07+0.27+5.6%$4.82$5.095$4.73903,000
$4.80+0.27+6.0%$4.55$4.865$4.551,065,400
$4.53+0.02+0.4%$4.52$4.65$4.51706,700
$4.51+0.05+1.1%$4.53$4.57$4.43723,300
$4.46+0.07+1.6%$4.64$4.72$4.35772,300
$4.39-0.01-0.2%$4.46$4.485$4.318508,400
$4.40+0.23+5.5%$4.22$4.41$4.20764,800
$4.17+0.04+1.0%$4.145$4.255$4.07497,500
$4.13-0.10-2.4%$4.28$4.28$4.06409,400
$4.23+0.175+4.3%$4.09$4.28$4.07509,400
Ticker
NASDAQ:IMRX
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Calls

Replays

  • Immuneering (NASDAQ:IMRX) Q3 2025 Earnings Call

    Wed, Nov 12, 2025 · 4:30 PM ET

    Watch Transcript

  • Immuneering (NASDAQ:IMRX) Q4 2022 Earnings Call

    Mon, Mar 06, 2023 · 4:30 PM ET

    Watch Transcript

Latest news

Immuneering Reports Third Quarter 2026 Financial Results and Provides Business Updates

Oct 29, 2026

Closed $3.75 (-6.8%) on Oct 30, 2026

Immuneering Presents Design and Methodology of Ongoing Phase 3 MAPKeeper 301 Trial at ESMO Congress 2026

Oct 26, 2026

Closed $3.71 (-0.5%) on Oct 26, 2026

Immuneering to Present at the 41st Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

Oct 2, 2026

Closed $4.07 (+1.0%) on Oct 2, 2026

Immuneering Presents Data at 2026 AACR Conference on Pancreatic Cancer Supporting Atebimetinib’s Mechanisms Designed to Extend Survival in Pancreatic Cancer

Sep 28, 2026

Closed $4.16 (-2.6%) on Sep 28, 2026

Immuneering to Present at the ESMO Congress 2026

Sep 24, 2026

Closed $4.34 (-0.9%) on Sep 24, 2026

Immuneering to Present at the AACR Conference on Pancreatic Cancer, Highlighting Atebimetinib’s Dual Mechanism for Extended Survival

Sep 10, 2026

Closed $4.57 (-0.9%) on Sep 10, 2026

Immuneering to Participate in Upcoming Investor Conferences

Sep 3, 2026

Closed $4.82 (-4.4%) on Sep 4, 2026

Immuneering Comments on Today’s FDA Approval in Second-Line Metastatic Pancreatic Cancer, Reiterates Focus on First-Line Patients

Aug 26, 2026

Closed $5.21 (+1.2%) on Aug 27, 2026

Immuneering Reports Second Quarter 2026 Financial Results and Provides Business Updates

Aug 5, 2026

Closed $4.39 (-0.2%) on Aug 5, 2026

Immuneering Corporation Announces Grants of Inducement Awards

Jul 17, 2026

Closed $4.29 (-7.5%) on Jul 20, 2026

All Immuneering Corporation news

Decks

Immuneering Corporation on 6ix

Sector
Health care
Industry
Biotechnology
News releases
29 in the last 12 months · 98 in all · newest Oct 29, 2026 · oldest 2021
Calls
2 calls with a replay · 2 with a transcript · latest Nov 12, 2025
Decks
5 decks · latest September 2026

Where Immuneering Corporation is listed

ListingExchangeCountryCurrency
NASDAQ:IMRX · Home listing · This pageNASDAQUnited StatesUSD
BOATS:IMRXBOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about Immuneering Corporation.